Institution
University College London Hospitals NHS Foundation Trust
Also known as: UCLH
- 100running trials
- 48closed trials
- 18,109publications (OpenAlex)
Running trials
Recruiting
REAL-MS: Observational Database Study of AHSCT and MS Therapies
Not yet recruiting
Recruiting
BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer
Recruiting
Recruiting
Recruiting
Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma
Recruiting
European Real-World Registry for Use of the Ion Endoluminal System
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Enrolling by invitation
Recruiting
Recruiting
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Recruiting
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Recruiting
Recruiting
Early DiAgnosis Real-Time Healthcare System for CANcer Trial
Active, not recruiting
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Recruiting
Recruiting
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Recruiting
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
Active, not recruiting
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Active, not recruiting
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
Active, not recruiting
Showing 50 of 100.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer11 recruiting
- Childhood cancers10 recruiting
- Prostate cancer6 recruiting
- Multiple myeloma4 recruiting
- Ovarian cancer4 recruiting
- Myelodysplastic syndromes3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Triple-negative breast cancer3 recruiting
- Acute myeloid leukaemia2 recruiting
- Crohn's disease2 recruiting
- Epilepsy2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Neuroblastoma2 recruiting
- Parkinson disease2 recruiting
- Spinal muscular atrophy2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- ALS (motor neurone disease)1 recruiting
- Alzheimer disease1 recruiting
- Amyloidosis1 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Follicular lymphoma1 recruiting
- Giant cell arteritis1 recruiting
- Haemophagocytic lymphohistiocytosis1 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Huntington's disease1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Mitochondrial disease1 recruiting
- Multiple sclerosis1 recruiting
- Myotonic dystrophy1 recruiting
- Obstructive sleep apnoea1 recruiting
- Polymyalgia rheumatica1 recruiting
- Sarcoma1 recruiting
- Spinal cord injury1 recruiting
- Thalassaemia1 recruiting
- Tourette syndrome1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
Completed
Terminated
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Completed
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
Completed
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
Completed
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Terminated
Terminated
Terminated
Completed
Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
Terminated
Completed
Completed
Completed
Completed
Completed
CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)
Terminated
Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Completed
Completed
Completed
Completed
Terminated
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
Completed
Completed
Completed
Completed
Completed
Completed
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
Completed
Completed
Registry name variants (20)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
University College London Hospitals NHS Foundation Trust
London, NW1 2PG
110 trials
University College London Hospital NHS Foundation Trust
London, W1T 7HA
11 trials
University College London Hospitals NHS Foundation Trust - University College Hospital
London, NW1 2PG
7 trials
University College London Hospitals NHS Foundation Trust (UCLH)
London, NW1 2BU
4 trials
University College Hospital, University College London Hospitals NHS Foundation Trust
London, NW1 2PG
2 trials
University College Hospitals London NHS Foundation Trust
London, Greater London NW1 2BU
1 trial
NCT04132895ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
Contact: The Chief Investigator
University College London Hospital NHS Foundation Trust (Site 0380)
London, London, City of NW1 2PG
1 trial
University College London Hospital NHS Foundation Trust (Site 1308)
London, London, City of NW1 2PG
1 trial
University College London Hospital NHS Foundation Trust (Site 1508)
London, London, City of NW1 2PG
1 trial
University College London Hospitals NHS Foundation Trust - Accepting Adult Patients
London, WC1N 3BG
1 trial
Contact: Dr. Pedro Machado, FRCP, PhD
University College London Hospitals NHS Foundation Trust (Site 0445)
London, London, City of NW1 2PG
1 trial
University College London Hospitals NHS Foundation Trust (Site 0454)
London, London, City of NW1 2PG
1 trial
University College London Hospitals NHS Foundation Trust (Site 1056)
London, Camden WC1E 6AG
1 trial
University College London Hospitals NHS Foundation Trust (Site 1901)
London, London, City of NW1 2BU
1 trial
University College London Hospitals NHS Foundation Trust (Site 2201)
London, London, City of NW1 2BU
1 trial
University College London Hospitals NHS Foundation Trust, University College Hospital London
London, NW1 2BU
1 trial
NCT05965479Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Contact: John Bridgewater
University College London Hospitals NHS Foundation Trust - University College Hospital (UCH) - Macmillan Cancer Centre
London
1 trial
Contact: Ioannis Charalampidis
University College London Hospitals NHS Foundation Trust | University College Hospital (UCLH) - Cancer Clinical Trials Unit
London, Greater London NW1 2PG
1 trial
University College London Hospitals - University College London Hospitals Nhs Foundation Trust
London, NW1 2BU
1 trial
University College London Hospital, University College London NHS Foundation Trust
London
1 trial
Contact: Vanessa Morris
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer81 works · 13 trials
- Multiple myeloma28 works · 8 trials
- Sarcoma20 works · 8 trials
- Endometriosis13 works · 0 trials
- Hodgkin lymphoma12 works · 2 trials
- Childhood cancers10 works · 17 trials
- Long COVID and ME/CFS9 works · 0 trials
- Ankylosing spondylitis9 works · 0 trials
- Lewy body dementia7 works · 0 trials
- Follicular lymphoma7 works · 3 trials
- Myeloproliferative neoplasms7 works · 7 trials
- Hepatitis B6 works · 0 trials
- Myotonic dystrophy5 works · 1 trial
- Pituitary tumours5 works · 0 trials
- Optic neuritis4 works · 0 trials
- Antiphospholipid syndrome4 works · 0 trials
- Multiple system atrophy3 works · 0 trials
Institution data: ROR 042fqyp44 (CC0-1.0)Updated 15 Nov 2026